Aurinia Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

13.05.20	Ausblick: Aurinia Pharmaceuticals stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net)
07.05.20	Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020 (Businesswire)
27.04.20	Aurinia Appoints Joe Miller as Chief Financial Officer (Businesswire)
20.04.20	Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors (Businesswire)
18.03.20	Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings (Businesswire)
17.03.20	Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland (Businesswire)
12.03.20	Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative (Businesswire)
05.03.20	Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights (Businesswire)
05.03.20	Ausblick: Aurinia Pharmaceuticals stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net)
03.03.20	Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020 (Businesswire)
25.02.20	Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team (Businesswire)
21.02.20	Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference (Businesswire)
12.12.19	Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares (Businesswire)
10.12.19	APTO On The Move, PLX To Effect Reverse Split, SCYX Plunges (RTTNews)
10.12.19	Aurinia Prices US$166.7 Million Public Offering of Common Shares (Businesswire)
09.12.19	Aurinia Announces Public Offering of Common Shares (Businesswire)
05.12.19	MÄRKTE USA/Wall Street abwartend vor US-Arbeitsmarktbericht (Dow Jones)
05.12.19	MÄRKTE USA/Wall Street gibt nach Anfangsgewinnen leicht nach (Dow Jones)
05.12.19	MÄRKTE USA/Wall Street startet mit leichten Gewinnen (Dow Jones)
05.12.19	AUPH Soars On Lupus Trial Results, ACAD On Watch, ALNA Trims Workforce (RTTNews)
05.12.19	Aurinia Pharma Shares Surge 125% On Positive Trial Results For Lupus Drug (RTTNews)
04.12.19	Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis (Businesswire)
03.12.19	Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference (Businesswire)
14.11.19	Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights (Businesswire)
13.11.19	Aurinia Announces Updates to the Board of Directors (Businesswire)
07.11.19	Aurinia Completes Voclosporin Drug-Drug Interaction Study Demonstrating No Clinically Significant Interaction With Mycophenolate Mofetil (Businesswire)
06.11.19	Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019 (Businesswire)
31.10.19	Aurinia Announces Initiation of Patient Dosing in Phase 2/3 AUDREY™ Clinical Trial for Dry Eye Syndrome (Businesswire)
16.10.19	Aurinia Reports Last Patient Study Visit in Aurora Phase 3 Lupus Nephritis Study and Provides Update on ATM Facility (Businesswire)
11.10.19	Healthcare Stocks That Plunged To New Lows(CTXR,AUPH,AAC...) (RTTNews)
11.10.19	5 Top Losers In Healthcare Sector (AKTX, COCP, AUPH…) (RTTNews)
07.10.19	5 Healthcare Stocks Facing Key Catalysts In Q4, 2019 (RTTNews)
26.09.19	Aurinia Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference (Businesswire)
13.09.19	Aurinia Establishes At-the-Market Facility (Businesswire)
06.09.19	Aurinia Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference (Businesswire)
06.08.19	Aurinia Reports Second Quarter 2019 Financial Results and Operational Highlights (Businesswire)
04.08.19	Ausblick: Aurinia Pharmaceuticals veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net)
01.08.19	Aurinia Pharmaceuticals to Release Second Quarter 2019 Financial Results on August 6, 2019 (Businesswire)
18.07.19	Aurinia Announces Further Strengthening of the Senior Management Team (Businesswire)
27.06.19	Aurinia Shareholders Elect all Eight Directors at 2019 Annual General Meeting (Businesswire)
21.06.19	Aurinia Reminds Shareholders to Vote the YELLOW Proxy Prior to June 24 Deadline (Businesswire)
07.06.19	Aurinia Issues Letter to Shareholders (Businesswire)
04.06.19	Aurinia Pharmaceuticals to Present at Upcoming Investor Conferences (Businesswire)
31.05.19	Aurinia Pharmaceuticals Announces Upcoming Annual General Meeting of Shareholders (Businesswire)
17.05.19	Aurinia Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference (Businesswire)
14.05.19	Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights (Businesswire)
12.05.19	Ausblick: Aurinia Pharmaceuticals legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net)
10.05.19	Aurinia Recognizes World Lupus Day and Lupus Awareness Month with Activities Focused on Raising Awareness for Lupus Nephritis (Businesswire)
09.05.19	Aurinia Pharmaceuticals to Release First Quarter 2019 Financial Results on May 14, 2019 (Businesswire)
30.04.19	Aurinia Further Strengthens Its Board of Directors with the Appointment of Dr. Daniel Billen (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Aurinia Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten